138 related articles for article (PubMed ID: 29269280)
21. Many purported pseudogenes in bacterial genomes are bona fide genes.
Cooley NP; Wright ES
BMC Genomics; 2024 Apr; 25(1):365. PubMed ID: 38622536
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
[TBL] [Abstract][Full Text] [Related]
23. HLA-HD: An accurate HLA typing algorithm for next-generation sequencing data.
Kawaguchi S; Higasa K; Shimizu M; Yamada R; Matsuda F
Hum Mutat; 2017 Jul; 38(7):788-797. PubMed ID: 28419628
[TBL] [Abstract][Full Text] [Related]
24. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
25. GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data.
De Summa S; Malerba G; Pinto R; Mori A; Mijatovic V; Tommasi S
BMC Bioinformatics; 2017 Mar; 18(Suppl 5):119. PubMed ID: 28361668
[TBL] [Abstract][Full Text] [Related]
26. Flexible, scalable, and efficient targeted resequencing on a benchtop sequencer for variant detection in clinical practice.
De Leeneer K; Hellemans J; Steyaert W; Lefever S; Vereecke I; Debals E; Crombez B; Baetens M; Van Heetvelde M; Coppieters F; Vandesompele J; De Jaegher A; De Baere E; Coucke P; Claes K
Hum Mutat; 2015 Mar; 36(3):379-87. PubMed ID: 25504618
[TBL] [Abstract][Full Text] [Related]
27. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
28. Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencing.
Hesson LB; Ward RL
Methods Mol Biol; 2014; 1167():265-74. PubMed ID: 24823784
[TBL] [Abstract][Full Text] [Related]
29. Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.
Sauvage V; Boizeau L; Candotti D; Vandenbogaert M; Servant-Delmas A; Caro V; Laperche S
PLoS One; 2018; 13(3):e0194366. PubMed ID: 29566006
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of immunodeficiency.
Tough DF
Nat Immunol; 2014 Dec; 15(12):1097-8. PubMed ID: 25396343
[TBL] [Abstract][Full Text] [Related]
31. Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies.
Picard C; Fischer A
Eur J Immunol; 2014 Oct; 44(10):2854-61. PubMed ID: 25154746
[TBL] [Abstract][Full Text] [Related]
32. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes.
Stefan CP; Koehler JW; Minogue TD
Sci Rep; 2016 May; 6():25904. PubMed ID: 27174456
[TBL] [Abstract][Full Text] [Related]
33. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches.
Ebbert MT; Wadsworth ME; Staley LA; Hoyt KL; Pickett B; Miller J; Duce J; ; Kauwe JS; Ridge PG
BMC Bioinformatics; 2016 Jul; 17 Suppl 7(Suppl 7):239. PubMed ID: 27454357
[TBL] [Abstract][Full Text] [Related]
35. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
[TBL] [Abstract][Full Text] [Related]
36. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction.
Mancuso DJ; Tuley EA; Westfield LA; Lester-Mancuso TL; Le Beau MM; Sorace JM; Sadler JE
Biochemistry; 1991 Jan; 30(1):253-69. PubMed ID: 1988024
[TBL] [Abstract][Full Text] [Related]
37. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
Mu W; Lu HM; Chen J; Li S; Elliott AM
J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
[TBL] [Abstract][Full Text] [Related]
38. Application of extensively targeted next-generation sequencing for the diagnosis of primary immunodeficiencies.
Kojima D; Wang X; Muramatsu H; Okuno Y; Nishio N; Hama A; Tsuge I; Takahashi Y; Kojima S
J Allergy Clin Immunol; 2016 Jul; 138(1):303-305.e3. PubMed ID: 26997321
[No Abstract] [Full Text] [Related]
39. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
40. Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome.
Orkunoglu-Suer F; Harralson AF; Frankfurter D; Gindoff P; O'Brien TJ
BMC Genomics; 2015 Apr; 16(1):264. PubMed ID: 25888426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
